Cargando…
HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach
Objectives. HER2 expression in gastric cancer (GC) has received attention as a potential target for therapy with Trastuzumab. We reviewed the current knowledge on HER2 status in premalignant gastric lesions and in early (EGC) and advanced (AGC) GC to discuss the possible pathogenetic and prognostic...
Autores principales: | Ieni, A., Barresi, V., Rigoli, L., Caruso, R. A., Tuccari, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606090/ https://www.ncbi.nlm.nih.gov/pubmed/26494937 http://dx.doi.org/10.1155/2015/234851 |
Ejemplares similares
-
Brachyury: A Diagnostic Marker for the Differential Diagnosis of Chordoma and Hemangioblastoma versus Neoplastic Histological Mimickers
por: Barresi, Valeria, et al.
Publicado: (2014) -
Morphological and Cellular Features of Innate Immune Reaction in Helicobacter pylori Gastritis: A Brief Review
por: Ieni, Antonio, et al.
Publicado: (2016) -
HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily
por: IENI, A., et al.
Publicado: (2013) -
Immunohistochemical Expression of Autophagy-Related Proteins in Advanced Tubular Gastric Adenocarcinomas and Its Implications
por: Ieni, Antonio, et al.
Publicado: (2019) -
Discordance Rate of HER2 Status in Primary Gastric Carcinomas and Synchronous Lymph Node Metastases: A Multicenter Retrospective Analysis
por: Ieni, Antonio, et al.
Publicado: (2014)